Immunicum: MERECA Update Confirms Ilixadencel Benefit
Research Note
2021-02-22
09:31
Redeye views today’s update from the MERECA as a positive and expected confirmation of previously reported results. We see no material changes to our valuation at this point.
NE
Niklas Elmhammer
Disclosures and disclaimers